HIV-1 genotypes in peripheral blood monocytes

Journal of Leukocyte Biology

Volumn 68, Issue 3, 2000, Pages 338-344

  Zhu, T ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

CD14+ monocytes; Genotype; HIV 1

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN;

GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD14; CD4-POSITIVE T-LYMPHOCYTES; GENOTYPE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MONOCYTES; SEQUENCE HOMOLOGY, AMINO ACID;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033638920     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. The role of mononuclear phagocytes in HTLV-III/LAV infection
2. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients
3. + T cells depletion and viral replication in SIV infection
4. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes
5. + memory T cells by human immunodeficiency virus type 1: Evidence for a role in the selective T-cell functional defects observed in infected individuals
6. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection
7. Viral dynamics in HIV-1 infection
8. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages
9. Mononuclear phagocytes of blood and bone marrow: Comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections
10. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1)
11. Chemokines and HIV replication
12. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1
13. Genotypic and phenotypic characterization of HIV-1 patients with primary infection
14. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule
15. Selection for specific sequences in the external envelope protein of HIV-1 upon primary infection
16. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission
17. CC CKR5: A RANTES, MIP-1(,MIP-1(receptor as a fusion cofactor for macrophage-tropic HIV-1
18. The (-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
19. Identification of a major co-receptor for primary isolates of HIV-1
20. + cells is mediated by the chemokine receptor CC-CKR-5
21. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
22. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
23. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
24. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression
25. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
26. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus
27. Integration of murine leukemia virus DNA depends on mitosis
28. Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes
29. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells
30. Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: Evidence of macrophage-dependent viral amplification
31. Role of cytokines in the pathogenesis of human immunodeficiency virus infection
32. Genetic relationships determined by a heteroduplex mobility assay: Analysis of HIV env genes
33. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays
34. Selective transmission of human immunodeficiency virus type 1 variants from mothers to infants
35. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: Evidence for viral compartmentalization and selection during sexual transmission
36. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection
37. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection
38. Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins
39. Presence of an inducible HIV-1 latent reservoirs during highly active antiretroviral therapy
40. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
41. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
42. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
43. + T cells during primary HIV-1 infection
44. Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine
45. In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop
46. Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS
47. Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease
48. Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous
49. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations
50. Genomic variation of human immunodeficiency virus type 1 (HIV-1): Molecular analyses of HIV-1 in sequential blood samples and various organs obtained at autopsy
51. Concurrent evolution of regions of the envelope and polymerase genes of human immunodeficiency virus type 1 during zidovudine (AZT) therapy
52. Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex
53. Distinct populations of human immunodeficiency virus type 1 in blood and cerebrospinal fluid
54. Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys
55. Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS
56. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1
57. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys
58. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
59. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition
60. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection
61. HIV-1 V3 domain variation in brain and spleen of children with AIDS: Tissue-specific evolution within host-determined quasispecies
62. Human immunodeficiency virus type 1 strains in the lungs of infected individuals evolve independently from those in peripheral blood and are highly conserved in the C-terminal region of the envelope V3 loop
63. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: Evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences
64. Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes
65. Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus
66. Decay characteristics of HIV-1 infected compartments during therapy
67. Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17 gag and env genes
68. In vivo compartmentalization of human immunodeficiency virus: Evidence from the examination of pol sequences from autopsy tissues
69. Human immunodeficiency virus type 1 populations in blood and semen
70. Signature pattern analysis: A method for assessing viral sequence relatedness